Law360 has selected Lieff Cabraser partners Lin Y. Chan and Kelly McNabb to serve on its 2022 Editorial Advisory Boards. Lin was chosen for the Competition Editorial Advisory Board for the second consecutive term and Kelly is a new addition to the publication’s Product Liability Editorial Advisory Board.
Law360’s editorial advisory boards are intended “to get feedback on Law360‘s coverage and gain insight from top experts in the field on how best to shape future coverage.” Board members also provide Law360‘s reporters with an additional pool of potential story ideas and commentary sources.
Congratulations to Kelly and Lin!
About Lin Y. Chan
A partner in Lieff Cabraser’s San Francisco office, Lin Y. Chan has represented plaintiffs in employment, whistleblower law, and antitrust cases. Her successes at the firm include representing direct purchasers of titanium dioxide against the titanium dioxide manufacturers for conspiring to fix prices. She worked extensively on the case’s trial preparation, including drafting and arguing motions in limine. In 2013, the case settled before trial for $163 million.
In 2017, Lin won the prestigious award for “Outstanding Antitrust Achievement by a Young Lawyer” from the American Antitrust Institute for her work on the Cipro drug antitrust cases, as well as sharing Lieff Cabraser’s team award from the AAI for “Outstanding Private Practice Antitrust Achievement” for their work on the Cipro case. She has been consistently recognized as a top lawyer in her fields by Best Lawyers in America, Super Lawyers, and Benchmark Litigation. Between 2019 and 2021, Lawdragon identified her as one of the nation’s “500 Leading Plaintiff Employment Lawyers in America,” as well as one of the nations “500 Leading Plaintiff Financial Lawyers in America.”
About Kelly McNabb
A partner in Lieff Cabraser’s New York office, Kelly McNabb represents plaintiffs in class action and mass tort litigation concerning products liability. She has represented people and families who have been injured by dangerous and defective products manufactured by medical device and pharmaceutical companies. Kelly has played an integral role in litigation in state and federal courts across the country against manufacturers such as Zimmer, Stryker, Bristol-Myers Squibb, Johnson & Johnson, Daiichi-Sankyo, Olympus, and Bayer. Kelly has dedicated her practice to holding corporations accountable for injuries that devastate her clients.